195 related articles for article (PubMed ID: 32886750)
1. Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic.
Purtill D; Antonenas V; Chiappini P; Tong D; O'Flaherty E; Bajel A; Kabani K; Larsen S; Tan S; Hutchins C; Curtis DJ; Kennedy GA; Watson AM; Bai L; Greenwood M; Gottlieb DJ; Hamad N
Blood Adv; 2020 Sep; 4(17):4147-4150. PubMed ID: 32886750
[TBL] [Abstract][Full Text] [Related]
2. Cryopreservation of Allogeneic Hematopoietic Cell Products During COVID-19 Pandemic: Graft Characterization and Engraftment Outcomes.
Keyzner A; Azzi J; Jakubowski R; Sinitsyn Y; Tindle S; Shpontak S; Kwon D; Isola L; Iancu-Rubin C
Transplant Proc; 2023 Oct; 55(8):1799-1809. PubMed ID: 37210273
[TBL] [Abstract][Full Text] [Related]
3. Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected Grafts.
Jacob RP; Flynn J; Devlin SM; Maloy M; Giralt SA; Maslak P; O'Reilly RJ; Tonon JA; Perales MA; Avecilla ST; Cho C
Transplant Cell Ther; 2021 Aug; 27(8):697.e1-697.e5. PubMed ID: 33991721
[TBL] [Abstract][Full Text] [Related]
4. A French single-center experience on allogeneic stem cell transplant cryopreservation during severe acute respiratory syndrome coronavirus 2 pandemic.
Laroye C; Thilly N; Gauthier M; Luc A; Latger-Cannard V; Eschwege V; Bensoussan D; Pochon C; Campidelli A; Rubio MT; D'Aveni M; Decot V
Cytotherapy; 2023 Aug; 25(8):877-884. PubMed ID: 37178096
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the recovery of cryopreserved and thawed CD34+ and CD3+ cells collected for hematopoietic transplantation.
Fisher V; Khuu H; David-Ocampo V; Byrne K; Pavletic S; Bishop M; Fowler DH; Barrett AJ; Stroncek DF
Transfusion; 2014 Apr; 54(4):1088-92. PubMed ID: 24117879
[TBL] [Abstract][Full Text] [Related]
6. Leukocytapheresis variables and transit time for allogeneic cryopreserved hpc: better safe than sorry.
Fernandez-Sojo J; Horton R; Cid J; Azqueta C; Garcia-Buendia A; Valdivia E; Martorell L; Rubio-Lopez N; Codinach M; Aran G; Marsal J; Mussetti A; Martino R; Diaz-de-Heredia C; Ferra C; Valcarcel D; Linares M; Ancochea A; García-Rey E; García-Muñoz N; Medina L; Carreras E; Villa J; Lozano M; Gibson D; Querol S
Bone Marrow Transplant; 2022 Oct; 57(10):1531-1538. PubMed ID: 35804055
[TBL] [Abstract][Full Text] [Related]
7. Effects of extended transport on cryopreserved allogeneic hematopoietic progenitor cell (HPC) product quality and optimal methods to assess HPC stability.
Reddy OL; Sall MT; Dinh A; Cai Y; Ongkeko M; Arya N; Wilder J; Tran M; Jin P; Stroncek DF; Panch SR
Transfusion; 2023 Apr; 63(4):774-781. PubMed ID: 36975826
[TBL] [Abstract][Full Text] [Related]
8. Good Engraftment but Quality and Donor Concerns for Cryopreserved Hemopoietic Progenitor Cell Products Collected During the COVID-19 Pandemic.
Purtill D; Hutchins C; Kennedy G; McClean A; Fraser C; Shaw PJ; Chiappini P; Tao H; Ma DD; Kabani K; Bai L; Greenwood M; Bajel A; O'Flaherty E; Curtis DJ; Purins L; Perera T; Tan S; Butler A; Micklethwaite K; Antonenas V; Gottlieb D; Hamad N
Transplant Cell Ther; 2021 Dec; 27(12):1022.e1-1022.e6. PubMed ID: 34571211
[TBL] [Abstract][Full Text] [Related]
9. Graft Cryopreservation Does Not Impact Overall Survival after Allogeneic Hematopoietic Cell Transplantation Using Post-Transplantation Cyclophosphamide for Graft-versus-Host Disease Prophylaxis.
Hamadani M; Zhang MJ; Tang XY; Fei M; Brunstein C; Chhabra S; D'Souza A; Milano F; Phelan R; Saber W; Shaw BE; Weisdorf D; Devine SM; Horowitz MM
Biol Blood Marrow Transplant; 2020 Jul; 26(7):1312-1317. PubMed ID: 32283185
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site.
Wiercinska E; Schlipfenbacher V; Bug G; Bader P; Verbeek M; Seifried E; Bonig H
J Transl Med; 2021 Apr; 19(1):145. PubMed ID: 33832504
[TBL] [Abstract][Full Text] [Related]
11. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity.
Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J
Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677
[TBL] [Abstract][Full Text] [Related]
12. Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+ cells.
Feugier P; Bensoussan D; Girard F; Alla F; Schuhmacher A; Latger-Cannard V; Hulin C; Witz F; Witz B; Carret AS; Bordigoni P; Lederlin P; Janot C
Transfusion; 2003 Jul; 43(7):878-84. PubMed ID: 12823747
[TBL] [Abstract][Full Text] [Related]
13. Dominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.
Purtill D; Smith K; Devlin S; Meagher R; Tonon J; Lubin M; Ponce DM; Giralt S; Kernan NA; Scaradavou A; Stevens CE; Barker JN
Blood; 2014 Nov; 124(19):2905-12. PubMed ID: 25185264
[TBL] [Abstract][Full Text] [Related]
14. Manufacture of Autologous CD34
Keever-Taylor CA; Heimfeld S; Steinmiller KC; Nash RA; Sullivan KM; Czarniecki CW; Granderson TC; Goldstein JS; Griffith LM
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1463-1472. PubMed ID: 28602891
[TBL] [Abstract][Full Text] [Related]
15. Study of a new device for washing and concentrating cryopreserved hematopoietic stem cells and mononuclear cells: a single center experience.
Santurette CC; Charron M; Bouyer S; Houzé P; Binninger S; Lavergne A; Mercier M; Giraud C
Cytotherapy; 2022 Jan; 24(1):86-92. PubMed ID: 34690062
[TBL] [Abstract][Full Text] [Related]
16. Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells.
Mfarrej B; Vicari O; Ouffai S; Malenfant C; Granata A; Thevenet S; Chabannon C; Lemarié C; Calmels B
J Transl Med; 2022 Nov; 20(1):503. PubMed ID: 36329460
[TBL] [Abstract][Full Text] [Related]
17. Assessing deviations for HPCs obtained during COVID-19 (ADHOC): Evaluating impact of the COVID-19 pandemic on cellular therapy products and processes, the BEST collaborative study.
Thibodeaux SR; Coble D; Day V; Fontaine MJ; Gabelli M; Gardiner N; Geach T; Schwartz J; Vasovic LV; Wyre R; Girdlestone J;
Transfusion; 2023 Apr; 63(4):782-790. PubMed ID: 36924403
[TBL] [Abstract][Full Text] [Related]
18. Variable resistance to freezing and thawing of CD34-positive stem cells and lymphocyte subpopulations in leukapheresis products.
Berens C; Heine A; Müller J; Held SA; Mayer K; Brossart P; Oldenburg J; Pötzsch B; Wolf D; Rühl H
Cytotherapy; 2016 Oct; 18(10):1325-31. PubMed ID: 27491794
[TBL] [Abstract][Full Text] [Related]
19. Improved postthaw viability and in vitro functionality of peripheral blood hematopoietic progenitor cells after cryopreservation with a theoretically optimized freezing curve.
Tijssen MR; Woelders H; de Vries-van Rossen A; van der Schoot CE; Voermans C; Lagerberg JW
Transfusion; 2008 May; 48(5):893-901. PubMed ID: 18298597
[TBL] [Abstract][Full Text] [Related]
20. Meeting the COVID challenge: Optimizing vCD34
Chang A; Ragg SJ; Ma DD
Cytotherapy; 2022 Apr; 24(4):437-443. PubMed ID: 35086777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
